This is the first book of its kind to tie the metabolic syndrome with psychiatric disorders and raise the possibility that common antipsychotic treatments may have this type of adverse effect on patients. Presenting a complete overview and the relationship between insulin resistance syndrome and psychiatric and cognitive disorders, the book will be a welcome addition to the library of any psychiatrist, neurologist, endocrinologist, or research scientist. The book also discusses new treatments to help prevent metabolic complications among patients with neuropsychiatric illnesses, including schizophrenia, Alzheimer’s Disease, and major depression.
Table of Contents
Introduction. The Metabolic Syndrome: Much Ado About (almost) Nothing. Insulin Resistance in Schizophrenia and Major Depression. Insulin Resistance Syndrome and Alzheimer’s Disease. Insulin Resistance, Depressive Disorders, and Alzheimer’s Disease. Conclusion
NATALIE L. RASGON is Professor, Departments of Psychiatry and Behavioral Sciences, Obstetrics and Gynecology, Stanford University, California, and she is Director of the Center for Neuroscience in Women’s Health at the Stanford School of Medicine and Stanford Neuroscience Institute. Dr. Rasgon received her M.D. and Ph.D. in Obstetrics and Gynecology and Pathological Physiology from the Central Institute of Postgraduate Medical Education, Central Institute of General Pathology and Pathological Physiology, Academy of Medical Sciences, Moscow, Russia. Dr. Rasgon is the author of over 124 peer-reviewed articles, more than 25 book chapters, and is a reviewer for more than 25 medical journals specific to psychiatry, neuropharmacology, and obstetrics and gynecology.